BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 96 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $901,000 | +4.5% | 18,208 | +15.8% | 0.35% | +26.1% |
| Q1 2017 | $862,000 | -52.9% | 15,728 | -52.2% | 0.28% | -42.7% |
| Q4 2016 | $1,831,000 | -0.9% | 32,873 | -18.8% | 0.49% | +10.6% |
| Q3 2016 | $1,848,000 | -11.7% | 40,469 | -22.8% | 0.44% | +14.8% |
| Q2 2016 | $2,092,000 | +10.2% | 52,389 | -3.9% | 0.38% | +41.0% |
| Q1 2016 | $1,898,000 | -48.1% | 54,505 | -36.0% | 0.27% | -30.7% |
| Q4 2015 | $3,657,000 | +10.2% | 85,106 | +11.6% | 0.39% | +23.1% |
| Q3 2015 | $3,319,000 | +5.4% | 76,230 | +24.9% | 0.32% | +3.9% |
| Q2 2015 | $3,150,000 | +17.4% | 61,053 | -10.9% | 0.31% | +17.1% |
| Q1 2015 | $2,684,000 | -38.9% | 68,551 | -39.7% | 0.26% | -37.2% |
| Q4 2014 | $4,393,000 | +56.1% | 113,752 | +42.7% | 0.42% | +71.7% |
| Q3 2014 | $2,814,000 | +41.8% | 79,722 | +8.3% | 0.24% | +56.4% |
| Q2 2014 | $1,985,000 | +76.3% | 73,614 | +69.5% | 0.16% | +110.8% |
| Q1 2014 | $1,126,000 | – | 43,437 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |